Stay updated on ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Sign up to get notified when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.

Latest updates to the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a dedicated Locations section listing study sites in California, Georgia, Massachusetts, Minnesota, and Pennsylvania, and removed the prior California/Georgia/Massachusetts/Minnesota/Pennsylvania location blocks.SummaryDifference0.7%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedPublications are now described as automatically filled from PubMed with a new Revision: v3.3.2, replacing the previous note and Revision: v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding and operating status notice was removed from the page. The change does not affect the study data, eligibility criteria, or user actions on the ClinicalTrials.gov record.SummaryDifference0.4%

- Check62 days agoChange DetectedThe updated screenshots show a rearranged layout and minor styling changes, with no alterations to critical study data such as eligibility criteria, locations, enrollment, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange Detected- Added a government funding notice about potential delays and current operating status, plus a link to cc.nih.gov and opm.gov for updates. - Bumped version from v3.1.0 to v3.2.0.SummaryDifference4%

- Check98 days agoChange DetectedVersion bump to v3.1.0 and capitalization normalization from 'Beta thalassemia' to 'Beta Thalassemia'.SummaryDifference0.2%

Stay in the know with updates to ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.